Summarizing the World Health Organization’s 2023 Benzodiazepine Guidelines

Summarizing the World Health Organization’s 2023 Benzodiazepine Guidelines

On November 20, 2023, the World Health Organization’s (WHO) 2023 (Third Edition) Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological, and substance use disorders introduced revised guidelines. The mhGAP guideline supports countries to…

HHA, SAMHSA 2022 National Survey on Drug Use Finds Low Benzodiazepine Misuse

HHA, SAMHSA 2022 National Survey on Drug Use Finds Low Benzodiazepine Misuse

On November 13, 2023, the U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), released a report titled “Key Substance Use and Mental Health Indicators in…

Call to Action: Could You Have an Illinois Medical Malpractice Case?

Call to Action: Could You Have an Illinois Medical Malpractice Case?

We are searching for patients who experienced abrupt benzodiazepine discontinuation connected to the state of Illinois. Those abruptly discontinued from benzodiazepine medication may face significant losses that justify legal action. These losses may be quite…